Weber Shandwick wins Boehringer Ingelheim diabetes drug brief
By Gemma O'Reilly, PR Week UK, 26 November 2009, 12:00am
Global pharmaceutical firm Boehringer Ingelheim has called in the first PR agency for its diabetes medication.
Share this story
To continue enjoying this article, please sign in. You can register for free for limited further access, or subscribe now for full access to all our content. View our subscription and registration options.





